SONIRE Announces First Patient Enrolled in Randomized Phase 2 Study of Its Novel HIFU Therapy System for Unresectable Pancreatic Cancer Patients in Japan ...Middle East

TOKYO, Feb. 2, 2023 /PRNewswire/ -- SONIRE Therapeutics Inc. (hereinafter referred to as "SONIRE"), based in Tokyo, announces that it has commenced a randomized phase 2 study for the treatment of unresectable pancreatic cancer with SONIRE's next-generation High-Intensity Focused...

Hence then, the article about sonire announces first patient enrolled in randomized phase 2 study of its novel hifu therapy system for unresectable pancreatic cancer patients in japan was published today ( Thursday 02/02/2023 - 09:12 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SONIRE Announces First Patient Enrolled in Randomized Phase 2 Study of Its Novel HIFU Therapy System for Unresectable Pancreatic Cancer Patients in Japan )

Also on site :

• 1979 Supertramp Hit, Ranked Among the ‘Greatest Classic Rock Songs’ Ever, Was Partially Recorded in a Bathroom
• Inside ‘Married at First Sight’ Season 20: How Peacock’s Changes Led to 1.8 Billion Minutes Viewed, That Wild Reunion and Why Lindsay Hubbard Said No to the Show
• Martha Stewart’s Retro 1960s-Inspired Bakeware Collection Brings Joy to Home Kitchens, Starting at $12